We confirm that EpCAM expression is associated with increased breast cancer invasion in vitro and in vivo, and demonstrate for the first time that EpCAM expression is capable of modulating the JNK/AP-1 signal transduction pathway. This evidence concerns the gene JUN and breast carcinoma.